Press release
Visceral Leishmaniasis Treatment Market 2024-2031 Explosive Growth, Highly Accurate Outlook 2024-2031 - Merck KGaA, PRG Pharma, LEXICARE PHARMA PVT. LTD.
The Visceral Leishmaniasis Treatment Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/visceral-leishmaniasis-treatment-market
What is the projected growth rate (CAGR) of the Global Visceral Leishmaniasis Treatment market from 2024 to 2031, and what is the market value expected to change by 2031?
The Visceral Leishmaniasis Treatment Market is valued at a significant CAGR during the forecast period (2024-2031).
Visceral leishmaniasis treatment involves combating the parasitic infection caused by Leishmania species, transmitted by sandflies. Treatments typically include antimonial drugs, amphotericin B, or miltefosine, depending on the disease severity and region. Early diagnosis is crucial to prevent life-threatening complications like organ failure. Research efforts focus on developing vaccines and less toxic, cost-effective therapies. Public health initiatives aim to improve access to treatment in endemic regions.
Key Developments:
❁ On March 30, 2023, Gilead Sciences, Inc. announced it will recalculate the no-profit cost of AmBisome (amphotericin B liposome for injection, 50mg/vial) for use in treating cryptococcal meningitis and visceral leishmaniasis in low- and middle-income countries. This adjustment aims to ensure the sustainable supply of AmBisome for Gilead's global access initiatives, benefiting governments and non-governmental health organizations in the public sector. The effort underscores Gilead's commitment to addressing critical healthcare needs in underserved regions.
List of the Key Players in the Visceral Leishmaniasis Treatment Market:
Merck KGaA, PRG Pharma, LEXICARE PHARMA PVT. LTD., SanMak Pharmaceuticals Private Limited, Pfizer Inc., Avet Pharmaceuticals Inc., Profounda Pharmaceuticals,Knight Therapeutics Inc., Sun Pharmaceutical Industries Ltd. and Gilead Sciences, Inc.
Research Process:
Both primary and secondary data sources have been used in the global Visceral Leishmaniasis Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Segment Covered in the Visceral Leishmaniasis Treatment Market:
By Drug Type: Pentavalent Antimonials (Sodium Stibogluconate (Pentostam), Meglumine Antimoniate (Glucantim), Antimicrobials (Paromomycin, Miltefosine), Antifungal (Amphotericin B Liposomal).
By Route of Administration: Oral, Intravenous, Others.
By End User: Hospitals, Ambulatory Surgical Centers, Others.
Regional Breakout:
The global Visceral Leishmaniasis Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
✫ North America (U.S., Canada, Mexico)
✫ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Get Year End Discounts on Premium Report:- https://www.datamintelligence.com/buy-now-page?report=visceral-leishmaniasis-treatment-market
This Report Unveils:
✔ Go to Market Strategy- A roadmap to successfully product launch or service in the target market.
✔ Gain a clear picture of the market's health and growth trajectory through neutral analysis.
✔ Deep Market Insights delve into development trends, competitor landscape, supply and demand dynamics, brand share & pricing analysis year-over-year growth patterns, and key players' performance.
✔ Upon request, we can provide customized reports focusing on specific regions or countries, offering a granular view of their markets.
✔ Identify high-potential niche segments and regions poised for significant expansion.
✔ Analysis of Market Size (historical and forecast) Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) to understand the market's overall size and your achievable market share.
✔ Gain a comprehensive understanding of the competitive landscape, including market share distribution, key players (innovators, startups, laggards, and pioneers), and their respective strengths and weaknesses.
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Visceral Leishmaniasis Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Visceral Leishmaniasis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the Visceral Leishmaniasis Treatment market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the Visceral Leishmaniasis Treatment market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/visceral-leishmaniasis-treatment-market
Frequently Asked Questions
☞ What is the expected growth rate of the global Visceral Leishmaniasis Treatment market for the forecast period?
☞ What are the key driving factors that are responsible to shape the fate of the Visceral Leishmaniasis Treatment market during the forecast period?
☞ What will be the overall size of the market during the analysis period?
☞ What are the prominent market trends which influence the development of the Visceral Leishmaniasis Treatment market across various regions?
☞ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?
☞ What are the challenges and threats that are likely to act as a barrier to the growth of the Visceral Leishmaniasis Treatment market?
☞ What are the major opportunities that the companies can get to attain success in the world?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Visceral Leishmaniasis Treatment Market 2024-2031 Explosive Growth, Highly Accurate Outlook 2024-2031 - Merck KGaA, PRG Pharma, LEXICARE PHARMA PVT. LTD. here
News-ID: 3738566 • Views: …
More Releases from DataM Intelligence 4market Research LLP

United States Kosher Food Market Expected to Reach USD 32.69 Billion by 2032, Dr …
Kosher Food Market Size reached US$ 23.47 billion in 2024 and is expected to reach US$ 32.69 billion by 2032, growing with a CAGR of 4.23% during the forecast period 2025-2032.
Kosher food refers to food that complies with Jewish dietary laws (kashrut), ensuring it meets specific preparation, ingredient, and handling standards. The global kosher food market is witnessing steady growth due to rising awareness of dietary preferences, health-conscious consumer trends,…

Bone Anchored Hearing Aids Market Poised for Strong Growth with Technological Ad …
The Bone Anchored Hearing Aids Market was valued at USD 226.9 million in 2021. It is forecasted to reach USD million by 2031, growing at a CAGR of 7.89% during the forecast period (2024-2031).
Bone Anchored Hearing Aids (BAHAs) are implantable hearing devices that transmit sound through bone conduction, bypassing the outer and middle ear to directly stimulate the cochlea. They are primarily used to treat conductive hearing loss, mixed hearing…

Automotive Intelligent Glass Market Trends Highlight Growth Opportunities in EVs …
The Automotive Intelligent Glass Market is anticipated to reach at a CAGR of 8.0% during the forecast period.
Automotive intelligent glass refers to advanced glazing solutions that can dynamically control light, heat, and privacy in vehicles, enhancing safety, comfort, and energy efficiency. The market is expanding due to the rising adoption of electric vehicles (EVs), luxury vehicles, and connected cars, as well as increasing consumer demand for smart cabin technologies. Key…

Sustainable Solutions: Biodegradable Straws Market Insights 2025-2031 | Top Comp …
Biodegradable Straws Market is growing at a CAGR of 41.1% during the forecast period (2024-2031).
Biodegradable straws are sustainable alternatives to traditional plastic straws. They are designed to naturally decompose in the environment through microbial action in conditions like composting or marine settings. These straws are commonly made from materials such as paper, PLA (polylactic acid), PHA, bamboo, seaweed, rice, and wheat.
📌 Download Sample Report to Identify Emerging Deals & Opportunities…
More Releases for Visceral
Visceral Leishmaniasis Market Generated Opportunities, Future Scope 2025-2032
The most recent report published by WMR indicates that the "Visceral Leishmaniasis Market" is likely to accelerate significantly in the next few years. The Visceral Leishmaniasis Market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The Visceral Leishmaniasis Market study includes information on market factors such as the market dynamics, drivers, restraints, challenges,…
Innovative NHE3 Inhibitor Advances Visceral Pain Treatment Industry Trends Gaini …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Visceral Pain Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for visceral pain has seen a significant rise in the past few years. The prediction is that it will increase from $13.84 billion in 2024 to $14.87 billion in 2025, with a…
Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expans …
The Visceral Pain Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Visceral Pain Market Size During the Forecast Period?
There has been a significant expansion in the size of the visceral pain market in past years. The market is projected to increase…
Visceral Leishmaniasis Market Share, Size, Trends and Global Forecast
The Visceral Leishmaniasis Treatments Market Is Set To Grow At An Estimated CAGR Of 6.6% From 2025 To 2034, Rising From $580 Million In 2024 To $1.1 Billion By 2034.
On April 15, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Visceral Leishmaniasis market goods. The market study excludes key regions that are accelerating marketization. This…
Key Influencer in the Visceral Pain Market 2025: Notable Surge In Buprenorphine …
What market dynamics are playing a key role in accelerating the growth of the visceral pain market?
The visceral pain market's growth is anticipated to be powered by an increasing need for analgesics. These pain relievers work by reducing or inhibiting the brain's perception of pain signals, providing relief from visceral pain by affecting the nervous system and controlling pain signals from the internal organs. The New England Journal of Medicine,…
Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expans …
What Are the Projections for the Size and Growth Rate of the Visceral Pain Market?
Over the past few years, significant expansion has occurred in the visceral pain market. The projection is for it to escalate from a value of $13.84 billion in 2024 to a value of $14.87 billion in 2025, a compound annual growth rate (CAGR) of 7.5%. The surge during the historical growth cycle has been driven by…